4.2 Article

Generation of integration-free induced pluripotent stem cell lines derived from two patients with X-linked Alport syndrome (XLAS)

Journal

STEM CELL RESEARCH
Volume 25, Issue -, Pages 291-295

Publisher

ELSEVIER
DOI: 10.1016/j.scr.2017.08.019

Keywords

-

Funding

  1. Fundacio La Marato de TV3 [121330]
  2. Instituto de Salud Carlos III-ISCIII/FEDER (Red de Terapia Celular -TerCel) [RD16/0011/0024]
  3. RETIC REDINRENRD [16/0009]
  4. Plataformade Recursos Biomoleculares y Bioinformaticos/PRB2 [PT13/0001/0041, PI13/01731, PI15/01824, PI16/01998]
  5. Spanish Ministry of Economy and Competitiveness-MINECO [SAF2015-69706-R]
  6. AGAUR [2014-SGR1460, 2014-SGR-1441, 2014-SGR-1564]
  7. CERCA Programme/Generalitat de Catalunya

Ask authors/readers for more resources

Skin biopsies were obtained from two male patients with X-linked Alport syndrome (XLAS) with hemizygous COL4A5 mutations in exon 41 or exon 46. Dermal fibroblastswere extracted and reprogrammed by nucleofection with episomal plasmids carrying OCT3/4, SOX2, KLF4 LIN28, L-MYC and p53 shRNA. The generated induced Pluripotent Stem Cell (iPSC) lines AS-FiPS2-Ep6F-28 and AS-FiPS3-Ep6F-9 were free of genomically integrated reprogramming genes, had the specific mutations, a stable karyotype, expressed pluripotency markers and generated embryoid bodies which were differentiated towards the three germ layers in vitro. These iPSC lines offer a useful resource to study Alport syndrome pathomechanisms and drug testing. (C) 2017 The Authors. Published by Elsevier B.V.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available